IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1688 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (1,044 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed641    
    Printed3    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
NET LETTER
Year : 2017  |  Volume : 83  |  Issue : 1  |  Page : 136

Lip swelling: An unusual presentation of post kala-azar dermal leishmaniasis


1 Department of Dermatology, Katihar Medical College, Katihar, Bihar, India
2 Department of Dermatology, All Institute of Medical Sciences, Patna, Bihar, India
3 Department of Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal, India

Date of Web Publication2-Dec-2016

Correspondence Address:
Piyush Kumar
Department of Dermatology, Katihar Medical College, Katihar, Bihar
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.192957

Rights and Permissions



How to cite this article:
Kumar P, Jha A, Das A. Lip swelling: An unusual presentation of post kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol 2017;83:136

How to cite this URL:
Kumar P, Jha A, Das A. Lip swelling: An unusual presentation of post kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol [serial online] 2017 [cited 2017 Mar 28];83:136. Available from: http://www.ijdvl.com/text.asp?2017/83/1/136/192957


Sir,

A 55-year-old otherwise healthy man presented with an asymptomatic, gradually increasing, firm, non-tender localized swelling affecting the left half of the upper lip for the preceding 8 months [Figure 1]a. There were no surface changes and the cervical lymph nodes were unremarkable. In the recent past, he had also developed many hypopigmented lesions on the trunk which were diagnosed as pityriasis versicolor by a physician and was treated with antifungals, without any improvement. Multiple hypopigmented macules, coalescing to form patches were seen over the trunk [Figure 1]a. There was no sensory loss over the hypopigmented lesions or elsewhere and none of the peripheral nerves were thickened. A provisional diagnosis of granulomatous cheilitis was considered for the lip lesion and a biopsy was performed for confirmation. Histopathologic examination showed an atrophic epidermis and a diffuse dense infiltrate of lymphocytes, plasma cells and macrophages involving the upper and mid-dermis [Figure 2]a. Many of the macrophages contained tiny, slightly basophilic, intracytoplasmic dots of size 1–2 microns, suggesting Leishman–Donovan bodies [Figure 2]b. Based on the clinicpathological findings, a diagnosis of post kala-azar dermal leishmaniasis was made.
Figure 1a: Multiple hypopigmented macules coalescing to form patches on trunk

Click here to view
Figure 1b: Resolution of the lip lesion, 3 months after treatment with miltefosine

Click here to view
Figure 2a: Atrophic epidermis and dense infiltration of lymphocytes, plasma cells and macrophages in upper dermis (H and E, ×100)

Click here to view
Figure 2b: Leishman–Donovan body (Arrow) (H and E, ×1000)

Click here to view


The patient was specifically probed for a history of kala-azar. He remembered having prolonged fever 15 years back for which he was treated with some injections after which the fever subsided. We treated him with oral miltefosine, 50 mg twice daily for 28 days, available under the national vector-borne diseases control programme in India. Following treatment for 28 days, the lip lesion showed significant improvement but resolution was incomplete. Treatment was continued for another 2 months followed by almost complete subsidence of the lesion [Figure 1]b.

Post kala-azar dermal leishmaniasis is a late cutaneous manifestation of visceral leishmaniasis caused by Leishmania donovani and is seen in 5–15% of visceral leishmaniasis cases in India.[1] The interval between the occurrence of kala-azar and post kala-azar dermal leishmaniasis ranges from 1 to 20 years (mean 6.2 years) in Indian post kala-azar dermal leishmaniasis, unlike African post kala-azar dermal leishmaniasis that usually develops some months to a year following visceral leishmaniasis.[2] In endemic areas, mucosal involvement can occur as granulomatous nodules on the angles of mouth, dorsum of tongue, buccal mucosa or soft palate.[3] In addition, mucosal leishmaniasis may affect the upper respiratory tract and/or oral mucosa leading to ulcerations, mainly in the hard or soft palate.[3]

Demonstration of parasites in slit-skin smear or by tissue culture is considered to be the gold standard, but such methods are invasive and less sensitive (58%) because of the low parasite burden and thus, not feasible in field conditions.[1] On the contrary, the recent availability of rapid serodiagnostic tools such as rK39 has revolutionized the diagnosis of visceral leishmaniasis as well as post kala-azar dermal leishmaniasis. The test has a sensitivity of around 95% for polymorphic post kala-azar dermal leishmaniasis and 78% for the macular variety.[4] Histopathology from the lesion is diagnostic and usually shows an infiltrate of chronic inflammatory cells with variable numbers of amastigotes in dermal macrophages.[1]

The synthetic phospholipid derivative, miltefosine, has been tried in different doses and duration for the treatment of post kala-azar dermal leishmaniasis. There has been a report on the efficacy of miltefosine at a higher dose of 50 mg thrice daily for 60 days (with a need to extend for 90 days if required) in a small number of patients of post kala-azar dermal leishmaniasis from Bangladesh.[5] Amphotericin B as a monotherapy and in combination has been found to be effective in doses of 5–20 mg/kg.[6]

To conclude, the index of suspicion for post kala-azar dermal leishmaniasis should be high in an endemic area, as atypical presentations are not uncommon.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Salotra P, Singh R. Challenges in the diagnosis of post kala-azar dermal leishmaniasis. Indian J Med Res 2006;123:295-310.  Back to cited text no. 1
    
2.
Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 2003;3:87-98.  Back to cited text no. 2
    
3.
Motta AC, Lopes MA, Ito FA, Carlos-Bregni R, de Almeida OP, Roselino AM. Oral leishmaniasis: A clinicopathological study of 11 cases. Oral Dis 2007;13:335-40.  Back to cited text no. 3
    
4.
Salotra P, Sreenivas G, Ramesh V, Sundar S. A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis. Br J Dermatol 2001;145:630-2.  Back to cited text no. 4
    
5.
Ramesh V, Katara GK, Verma S, Salotra P. Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis. Br J Dermatol 2011;165:411-4.  Back to cited text no. 5
    
6.
Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, et al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India:An open-label, non-inferiority, randomised controlled trial. Lancet 2011;377:477-86.  Back to cited text no. 6
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]



 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow